Testing a new sheath for transcatheter aortic valve replacement
Part of Heart & circulation clinical trials.
This trial tests a special sheath called ArcFlex for TAVR surgery. It aims to see if it works well for people who need their aortic valve replaced through a catheter in the leg.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need a severe aortic valve problem that requires a TAVR procedure.
- You should have symptoms like shortness of breath or chest pain (NYHA class II or higher).
- Your doctor must confirm that the blood vessels in your leg can safely handle the procedure.
- You are expected to live at least one more year.
- You are willing to sign a consent form and come for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial is studying how well a new type of heart valve works in real-life patients with aortic valve disease. It will help doctors understand if this valve is safe and effective for people who need a procedure called TAVR (transcatheter aortic valve replacement).
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial studies how safe and effective the NAVITOR valve is for treating narrowed aortic valves placed through a catheter (no open-heart surgery). It may be an option if you’re at intermediate-to-low surgical risk and meet heart ultrasound/CT measurements.
This study checks whether an “investigational” transcatheter aortic valve is safe and works well for people with severe, calcified aortic stenosis (a stiff, narrowed heart valve). It may help improve valve function and symptoms, but you must meet specific heart, scan, and health-status requirements.
Hear when a new Valve Disease, Aortic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.